Sort
40,608 grants matching “prostate cancer”
Curcuma Longa: epigenetic effects in prostate and colon cancer
$463,811Ah-Ng Tony Kong · Rutgers, The State Univ Of N.J. · R01 · FY2016 · AT
Curcuma Longa: epigenetic effects in prostate and colon cancer
$463,811Ah-Ng Tony Kong · Rutgers, The State Univ Of N.J. · R01 · FY2012 · AT
LHRH Synthetic Peptide Vaccine for Prostate Cancer
$463,803United Biomedical, Inc. · R44 · FY2002 · CA
NYU COOPERATIVE PROSTATE CANCER TISSUE RESOURCE
$463,767New York University School Of Medicine · U01 · FY2002 · CA
Ras-mediated signals in human epithelial cell transformation and metastasis
$463,709Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$463,686Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Agents for Specific NMR and SQUID Imaging of Prostate Cancer
$463,665Laurel O Sillerud · University Of New Mexico · R01 · FY2010 · CA
Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards
$463,634Gregory S Karczmar · University Of Chicago · R01 · FY2015 · CA
Prospective validation of a multi-marker prostate cancer prediction model
$463,618Hans Gãsta Lilja · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Prostate-Specific Antigen Practices and Outcomes in the Elderly
$463,572Louise C. Walter · Northern California Institute/Res/Edu · R01 · FY2009 · CA
STROMAL MODULATION BY THE SECRETORY FACTORS OF NEUROENDOCRINE-LIKE PROSTATE CANCER
$463,500Virginia Commonwealth University · · FY2025 · Defense Health Agency
Targeting chemoresistant prostate cancer with novel EED inhibitors
$463,429Daqing Wu · Clark Atlanta University · R01 · FY2023 · CA
Core C: Pathology, Biospecimen and Immune Profiling
$463,372Tamara Levin Lotan · University Of Southern California · U19 · FY2022 · CA
Chemoprevention of Prostate Cancer, HDAC Inhibition, and DNA Methylation
$463,297Emily Ho · Texas A&M University Health Science Ctr · P01 · FY2014 · CA
Measurement Errors in Cancer Epidemiology
$463,287Donna L Spiegelman · Harvard School Of Public Health · R01 · FY2008 · CA
The origins of metabolic reprogramming in prostate cancer
$463,272Andrew S Goldstein · University Of California Los Angeles · R01 · FY2019 · CA
Myosin VI: a new ubiquitin receptor
$463,245Kylie Walters · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
RIPK2/MKK7/c-Myc Signaling as a Therapeutic Target in Prostate Cancer Metastasis
$463,166Wei Yang · State University New York Stony Brook · R01 · FY2025 · CA
Increasing nerve-sparing radical prostatectomy rates using intraoperative nonlinear microscopy
$463,165James G Fujimoto · Massachusetts Institute Of Technology · R01 · FY2024 · CA
Human Leukemia Growth Inhibition by a Novel Retinoid
$463,144Joseph A Fontana · Wayne State University · R01 · FY2008 · CA
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer
$463,114Kathryn L Penney · Brigham And Women'S Hospital · R37 · FY2021 · CA
Longevity and Medical Treatment in Old Age
$463,030Sharon R Kaufman · University Of California, San Francisco · R01 · FY2011 · AG
Project 2: Investigating cell intrinsic and extrinsic drivers of prostate cancer bone metastasis
$462,982Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2024 · CA
Molecular Targets for Cancer Detection and Treatment
$462,965William George Nelson · Johns Hopkins University · T32 · FY2007 · CA
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$462,850Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA